Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vasomedical Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Antonios Petropoulos who wrote (735)	11/14/1997 6:19:00 PM
From: Fred Levine	Read Replies (1) \| Respond to of 1605

Antonios--Sorry for not responding sooner, but I was out of town. The WSJ article was essentially the standard press release about the EECP study with additional info about the company. it pointed out that sales have slowed in 97 as opposed to 96 (or 96 from 96--I'm not sure), and that they are awaiting medicare reimbusement until a study comes out in May. It is not clear to me what additional data rea required. Otherwise the article was positive about the improved prospects after the MUST-EEPC study. What we have seen is hardly new; "Buy on rumor, sell on news." The company needs to "simply" demonstate increased sales-rentals, and we'll all do better. good investing--fred